Eltrombopag - 3SBioAlternative Names: SSS 20
Latest Information Update: 19 Sep 2016
At a glance
- Originator 3SBio
- Class Benzoates; Hydrazines; Pyrazoles; Small molecules
- Mechanism of Action Thrombopoietin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Idiopathic thrombocytopenic purpura
Most Recent Events
- 19 Sep 2016 Phase-I clinical trials in Idiopathic thrombocytopenic purpura in China (PO) before September 2016 (3SBio pipeline, September 2016)